ObjectivesThis is a five-year survival case report on non-small cell lung cancer (NSCLC) treated with western medicine and traditional Korean medicine. 44-year old man diagnosed NSCLC IIIB in 2015 went through two months’ concurrent chemoradiotherapy (CCRT) first, however the cancer did not response. After CCRT he began to take intensive integrative therapy including acupuncture, abdominal moxibustion, wild ginseng pharmacopuncture, herbal medicinal product of ginseng, hyperthermia, Thymosin α1, and mega vitamin C injection for 4 years and 9 months. After three months of intensive treatment, the state of cancer changed first to partial response and then complete response. He finally succeeded in five-year survival without any recurrence or complication in 2020, We suggest that integrative approach including traditional Korean medicine can be a meaningful treatment option for nonoperable NSCLC. Further studies with more cases should be performed to establish proper treatment protocol of integrative medicine for lung cancer.
참고문헌1. Annual Report of national cancer statistics in Korea in 2017. National Cancer Center;(2019.
2. Jeong, SH, Jung, JH, Lee, HW, Kang, SY, choi, YW, & Ahn, MS, et al. Concurrent Chemoradiotherapy with Weekly Paclitaxel for Locally Advanced Non-small Cell Lung Cancer. J Lung Cancer, (2009). 8(1), 8-12.
![]() 3. Wu, X, Chung, VC, Lu, P, Poon, SK, Hui, EP, & Lau, AY, et al. Chinese Herbal Medicine for Improving Quality of Life Among Nonsmall Cell Lung Cancer Patients: Overvies of Systematic Reviews and Network Meta-Analysis. Medicine, (2016). 95(1), e2410.
![]() ![]() ![]() 4. Liu, J, Lin, HS, Hou, W, Hua, BJ, Zhang, PT, & Li, J, et al. Comprehensive treatment with Chinese medicine in patients with advanced non-small cell lung cancer: A multicenter, prospective, cohort study. Chin J Integr Med, (2017). 23(10), 733-739.
![]() ![]() 5. Han, GJ, Cho, MJ, Park, EJ, Seong, S, Kim, SS, & Kim, KI, et al. Analysis of existing guidelines and randomized, controlled, clinical trials for development of [guideline of clinical trial with herbal medicinal product for lung cancer]. J Korean Med, (2019). 40(1), 153-173.
![]() 6. Jung, HJ, & Kim, JD. The Role of Korean Medicine for Treatment and Management for Lung Cancer. J Kor Trad Oncol, (2015). 20(1), 45-54.
![]() 7. Kin, KS. Case Study: Regression of a residual tumor and prolongation of overall survival with allergen-removed Rhus Verniciflua stokes after chemoradiotherapy in locally advanced non-small cell lung cancer. J Int Korean Med, (2015). 36(2), 200-206.
8. Park, SJ, Kang, HJ, Park, JH, Cho, CK, & Yoo, HS. A case report of a clinically diagnosed advanced lung cancer patient after treatment with Gunchilgyebok-Jung. J Kor Trad Oncol, (2015). 20(1), 23-29.
9. Zheng, HM, Yoon, JW, Lee, YW, Cho, CK, Ph, DS, & Yoo, HS. Case Series of advanced non-small cell lung cancer patients treated with Hang-am Plus. J Int Korean Med, (2011). 32(1), 113-120.
10. Park, SJ, Kim, SY, Cho, CK, Jung, IC, & Yoo, HS. Preliminary study to develop the instrument of oriental medical evaluation for lung cancer. J Korean Med, (2015). 36(3), 53-64.
![]() 11. Park JG, Bang YJ, Ha SH. Oncology. 2nd rev ed. Seoul. Iljogak;(2012). p. 224-239.
12. NCCN clinical practice guidelines in oncology (ver.8). National Comprehensive cancer network;(2020.
13. Costa, GJ, Ferreira, CG, & Thuler, CS. Concurrent chemoradiotherapy for stage III non-small cell lung cancer: corredt clinical management as the basis to move beyond. Ann Transl Med, (2018). 6(Suppl 1), S65.
![]() ![]() ![]() 14. Lee, JC, Yun, HY, Yoo, HS, & Bang, SH. A case report of complete response of advanced gastric carcinoma patient treated with Korean medicine treatment in conjuction with chemoradiation therapy. J Kor Trad Oncol, (2014). 19(1), 25-32.
15. Wust, P, Hildebrandt, B, Sreenivasa, G, Rau, B, Gellermann, J, & Riess, H, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol, (2002). 3(8), 487-497.
![]() 16. Garaci, E, Pica, F, Matteucci, C, Gaziano, R, D’Agostini, C, & Miele, MT, et al. Historical review on thymosin α1 in oncology: preclinical and clinical experiences. Expert Opin Biol Ther, (2015). 15(Suppl 1), S31-9.
![]() ![]() 17. Fritz, H, Flower, G, Weeks, L, Cooley, K, Callachan, M, & McGowan, J, et al. Intravenous Vitamin C and Cancer: A Systematic Review. Integr Cancer Ther, (2014). Jul. 13(4), 280-300.
![]() ![]() |
|